JAK Inhibitors for Treatment of SAPHO Syndrome: A Systematic Review of 72 Cases

Documenti analoghi

• Understanding Cardiovascular Events With JAK Inhibitors: Similarities and Differences of the Vascular Effects Between Different JAK Inhibitors on Endothelial Cells Exposed to Inflammatory Cytokines
  di: Aliki Zavoriti, et al.
  Pubblicazione: (2025)
• Characterization of Second‐Line Therapy After First JAK Inhibitor Use: Results From the CorEvitas Rheumatoid Arthritis Registry
  di: Joshua F. Baker, et al.
  Pubblicazione: (2025)
• Difficult‐to‐Treat Rheumatoid Arthritis With Concomitant Yao Syndrome With Response to Dual‐Inhibitor Therapy
  di: Nawar Aljundi, et al.
  Pubblicazione: (2026)
• Therapeutic JAK1 Inhibition Reverses Lupus Nephritis in a Mouse Model and Demonstrates Transcriptional Changes Consistent With Human Disease
  di: Rachel E. Twomey, et al.
  Pubblicazione: (2024)
• Safety of Immune Checkpoint Inhibitors in Cancer Patients With Preexisting Autoimmune Vasculitis
  di: Juan Sevillano, et al.
  Pubblicazione: (2026)